Although thought leaders love to pontificate about the convergence of media and creative on stage at industry conferences, media and creative teams at most brands operate as if they’re allergic to ...

Evaluating the effectiveness of a creative ad remains a critical, ongoing consideration for health brands. Improving content quality is more than just an exercise in creative pride, there are ...

To younger generations, heart disease may seem like a far-away risk relegated to Boomers and older generations. However, as elder millennials enter their early 40s, Bayer Aspirin believes it’s time ...

Bayer is working with custom algorithm firm Chalice AI and data partner Snowflake to create audiences for targeting ads.

Bayer is turning to the alphabet to explain the benefits of its new chronic disease drug, Kerendia, in its first TV ad. Launched this week, the German pharma’s 60-second commercial goes through some ...